A new Medicare option for weight loss drugs is coming
Digest more
MIAMI, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory diseases, today announced selection of a novel ...
New ACVIM Consensus Statement Highlights Visbiome Vet's De Simone Formulation in Diet-First Approach
ROCKVILLE, Md., Feb. 23, 2026 /PRNewswire/ -- ExeGi Pharma LLC, a leader in digestive health solutions and the manufacturer of the high-potency Visbiome Vet probiotic, today welcomed the publication of a new consensus statement from the American College of ...